摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,4-methylenedioxybenzoic acid 3,4-methylenedioxybenzylamide | 325694-56-2

中文名称
——
中文别名
——
英文名称
3,4-methylenedioxybenzoic acid 3,4-methylenedioxybenzylamide
英文别名
N-(1,3-benzodioxol-5-ylmethyl)-1,3-benzodioxole-5-carboxamide
3,4-methylenedioxybenzoic acid 3,4-methylenedioxybenzylamide化学式
CAS
325694-56-2
化学式
C16H13NO5
mdl
MFCD01345233
分子量
299.283
InChiKey
LOFYNGLWOLYFGJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    22
  • 可旋转键数:
    3
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.19
  • 拓扑面积:
    66
  • 氢给体数:
    1
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3,4-methylenedioxybenzoic acid 3,4-methylenedioxybenzylamide三溴化硼 作用下, 以 二氯甲烷 为溶剂, 反应 2.0h, 以35%的产率得到3,4-dihydroxybenzoic acid 3,4-dihydroxybenzylamide
    参考文献:
    名称:
    [EN] COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF AMYLOID DISEASES AND SYNUCLEINOPATHIES SUCH AS ALZHEIMER'S DISEASE, TYPE 2 DIABETES, AND PARKINSON'S DISEASE
    [FR] COMPOSES, COMPOSITIONS ET PROCEDES DE TRAITEMENT DE MALADIES AMYLOIDES ET DE SYNUCLEINOPATHIES, NOTAMMENT DE LA MALADIE D'ALZHEIMER, DU DIABETE DE TYPE 2 ET DE LA MALADIE DE PARKINSON
    摘要:
    双-和三-二羟基芳基化合物及其亚甲二氧基类似物和药用可接受酯,它们的合成,含有它们的药物组合物,以及它们在治疗淀粉样疾病,特别是Aß淀粉样病变,如阿尔茨海默病中观察到的,IAPP淀粉样病变,如2型糖尿病中观察到的,以及α-突触核病,如帕金森病中观察到的,以及用于制造用于此类治疗的药物。
    公开号:
    WO2003101927A1
  • 作为产物:
    描述:
    3,4-亚甲二氧基苄胺胡椒酸氯化亚砜吡啶 作用下, 以 二氯甲烷 为溶剂, 反应 1.5h, 以79%的产率得到3,4-methylenedioxybenzoic acid 3,4-methylenedioxybenzylamide
    参考文献:
    名称:
    [EN] COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF AMYLOID DISEASES AND SYNUCLEINOPATHIES SUCH AS ALZHEIMER'S DISEASE, TYPE 2 DIABETES, AND PARKINSON'S DISEASE
    [FR] COMPOSES, COMPOSITIONS ET PROCEDES DE TRAITEMENT DE MALADIES AMYLOIDES ET DE SYNUCLEINOPATHIES, NOTAMMENT DE LA MALADIE D'ALZHEIMER, DU DIABETE DE TYPE 2 ET DE LA MALADIE DE PARKINSON
    摘要:
    双-和三-二羟基芳基化合物及其亚甲二氧基类似物和药用可接受酯,它们的合成,含有它们的药物组合物,以及它们在治疗淀粉样疾病,特别是Aß淀粉样病变,如阿尔茨海默病中观察到的,IAPP淀粉样病变,如2型糖尿病中观察到的,以及α-突触核病,如帕金森病中观察到的,以及用于制造用于此类治疗的药物。
    公开号:
    WO2003101927A1
点击查看最新优质反应信息

文献信息

  • Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes, and parkinson's disease
    申请人:——
    公开号:US20040127555A1
    公开(公告)日:2004-07-01
    Bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs and pharmaceutically acceptable esters, their synthesis, pharmaceutical compositions containing them, and their use in the treatment of amyloid diseases, especially A&bgr; amyloidosis, such as observed in Alzheimer's disease, IAPP amyloidosis, such as observed in type 2 diabetes, and synucleinopathies, such as observed in Parkinson's disease, and the manufacture of medicaments for such treatment.
    双和三羟基芳基化合物及其亚甲二氧基类似物和药学上可接受的酯,其合成方法,包含它们的药物组成物,以及它们在治疗淀粉样疾病中的应用,特别是Aβ淀粉样蛋白病,如阿尔茨海默病,IAPP淀粉样蛋白病,如2型糖尿病中观察到的,以及突触核蛋白病,如帕金森病中观察到的,以及用于制造此类治疗药物。
  • Compounds, compositions and methods for the treatment of amyloid diseases such as systemic AA amyloidosis
    申请人:Snow D. Alan
    公开号:US20070225362A1
    公开(公告)日:2007-09-27
    Bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs and pharmaceutically acceptable esters, their synthesis, pharmaceutical compositions containing them, and their use in the treatment of amyloid diseases, especially Aβ amyloidosis, such as observed in Alzheimer's disease, IAPP amyloidosis, such as observed in type 2 diabetes, AA/SAA amyloidosis, such as observed in systemic AA amyloidosis and synucleinopathies, such as observed in Parkinson's disease, and the manufacture of medicaments for such treatment.
    双羟基和三羟基芳基化合物及其甲氧基二氧杂环化物和药学上可接受的酯类,它们的合成,含有它们的制药组合物,以及它们在治疗淀粉样疾病,特别是阿尔茨海默病中观察到的Aβ淀粉样变性,IAPP淀粉样变性,例如在2型糖尿病中观察到的AA / SAA淀粉样变性,以及突触蛋白病,例如在帕金森病中观察到的应用,以及用于制造这种治疗药物。
  • Compounds, compositions and methods for the treatment of synucleinopathies
    申请人:Esposito Luke
    公开号:US20070276034A1
    公开(公告)日:2007-11-29
    Bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs and pharmaceutically acceptable esters, their synthesis, pharmaceutical compositions containing them, and their use in the treatment of synucleinopathies, such as Parkinson's disease, and the manufacture of medicaments for such treatment.
    双-和三-二羟基芳基化合物及其亚甲二氧基类似物和药学上可接受的酯,它们的合成,含有它们的制药组合物,以及它们在治疗突触核病,如帕金森病中的应用和制造用于这种治疗的药物。
  • COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF AMYLOID DISEASES AND SYNUCLEINOPATHIES SUCH AS ALZHEIMER'S DISEASE, TYPE 2 DIABETES, AND PARKINSON'S DISEASE
    申请人:Snow Alan D.
    公开号:US20090069432A1
    公开(公告)日:2009-03-12
    Bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs and pharmaceutically acceptable esters, their synthesis, pharmaceutical compositions containing them, and their use in the treatment of amyloid diseases, especially Aβ amyloidosis, such as observed in Alzheimer's disease, IAPP amyloidosis, such as observed in type 2 diabetes, and synucleinopathies, such as observed in Parkinson's disease, and the manufacture of medicaments for such treatment.
    双-和三-二羟基芳基化合物及其二氧化甲基类似物和药学上可接受的酯,它们的合成,含有它们的制药组合物,以及它们在治疗淀粉样疾病中的应用,尤其是Aβ淀粉样蛋白病,如阿尔茨海默病,IAPP淀粉样蛋白病,如2型糖尿病,以及突触核病,如帕金森病,和用于制造这种治疗药物。
  • Compounds, compositions and methods for the treatment of inflammatory diseases
    申请人:Sanders J. Virginia
    公开号:US20070208087A1
    公开(公告)日:2007-09-06
    The use of a composition comprising a compound: where R is a C 1 -C 10 alkylene group, in which, when the number of carbon atoms is at least 2, there are optionally 1 or 2 non-adjacent double bonds; 1 to 3 non-adjacent methylene groups are optionally replaced by NR 1 (where R 1 is H, alkyl, or acyl), O, or S; and 1 or 2 methylene groups are optionally replaced by a carbonyl or hydroxymethylene group for the preparation of a medicament or a pharmaceutical for the treatment of inflammatory diseases.
    使用含有化合物的组合物:其中R是C1-C10烷基基团,当碳原子数至少为2时,可以选则1或2个非相邻的双键;1到3个非相邻的亚甲基团可以被NR1(其中R1为H,烷基或酰基)、O或S替换;并且1或2个亚甲基团可以被羰基或羟甲基基团替换,以制备用于治疗炎症性疾病的药物或制剂。
查看更多

同类化合物

(5-(4-乙氧基-3-甲基苄基)-1,3-苯并二恶茂) 黄樟素氧化物 黄樟素乙二醇; 2',3'-二氢-2',3'-二羟基黄樟素 黄樟素 风藤酰胺 非哌西特盐酸盐 非哌西特 盐酸盐 角秋水仙碱 螺[1,3-苯并二氧戊环-2,1'-环己烷]-5-胺 蓝细菌 苯并[d][1,3]二氧杂环戊烯-5-胺盐酸盐 苯并[d][1,3]二氧代l-5-甲基(2-氧代乙基)氨基甲酸叔丁酯 苯并[d][1,3]二氧代l-5-氨基甲酸叔丁酯 苯并[d][1,3]二氧代-4-甲腈 苯并[d][1,3]二氧代-4-氨基甲酸叔丁酯 苯并[d[1,3]二氧代-4-羧酰胺 苯并[1,3]二氧杂环戊烯-5-基甲基2-氯乙酸酯 苯并[1,3]二氧杂环戊烯-5-基甲基-苄基-胺 苯并[1,3]二氧杂环戊烯-5-基甲基-[2-(4-氟-苯基)-乙基]-胺 苯并[1,3]二氧杂环戊烯-5-基甲基-(四氢-呋喃-2-基甲基)-胺 苯并[1,3]二氧杂环戊烯-5-基甲基-(2-氟-苄基)-胺 苯并[1,3]二氧杂环戊烯-5-基甲基-(1-甲基-哌啶-4-基)-胺 苯并[1,3]二氧代l-5-甲基-吡啶-3-甲基-胺 苯并[1,3]二氧代l-5-甲基-(4-氟-苄基)-胺 苯并[1,3]二氧代l-5-乙酸甲酯 苯并[1,3]二氧代-5-羧酰胺盐酸盐 苯并[1,3]二氧代-5-甲基肼盐酸盐 苯并[1,3]二氧代-5-甲基吡啶-4-甲胺 苯并[1,3]二氧代-5-甲基-吡啶-2-甲胺 苯并[1,3]二氧代-5-乙酰氯 苯并-1,3-二氧杂环戊烯-5-甲醇丙酸酯 苯乙酸,1-(1,3-苯并二氧杂环戊烯-5-基)-3-丁烯-1-基酯 苯乙酮O-((4-(3,4-亚甲二氧基苄基)-1-哌嗪-1-基)羰基甲基)肟 苯,1-甲氧基-6-硝基-3,4-亚甲二氧基- 芝麻酚 胡椒醛肟 胡椒醛,二苄基缩硫醛 胡椒醛 胡椒醇 胡椒酸酰氯 胡椒酸 胡椒腈 胡椒环乙酮肟 胡椒环 胡椒基重氮酮 胡椒基甲醛 胡椒基氯 胡椒基戊二烯酸钾 胡椒基丙醛 胡椒基丙酮